Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| QIMR Berghofer Medical Research Institute | OTHER |
| Princess Alexandra Hospital, Brisbane, Australia | OTHER |
| Translational Research Institute, Brisbane, Australia | UNKNOWN |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is designed to refine the aetiological causes of cancers of the head and neck and investigate the ways in which human papillomavirus and life-style factors cause head and neck cancers. This study will determine if these factors affect the treatment of cancer.
All patients attending the Head and Neck Clinic at the Princess Alexandra Hospital is invited to complete a risk factor questionnaire and give consent for their clinical data and tissue samples to be available for future research activities. The risk factor questionnaire is based on existing validated instruments developed by the QIMR Berghofer Medical Research Institute Cancer Control Group, and will collect standardised information relating to demographics and causal factors (tobacco and alcohol intake), risk modifiers (dentition, asprin and non-steroidal anti-inflammatory drugs (NSAIDS), height, weight, physical activity, diet quality etc) and behaviours (oral sex etc)
Data is collected using a simple four-page paper-based questionnaire. Information to be collected include age, sex, height and weight (at age 20, current age, and heaviest ever), history of cancer (own and partner). Questions about recreational physical activity, smoking history and alcohol consumption, acid reflux, heartburn, denture use and tonsillectomy, frequency of use of paracetamol, antihistamine and NSAIDS.
The questionnaires also ask participants some detailed questions about sexual behaviour and history if they are comfortable to give this information.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Head and neck cancer | All patients presenting to the Head and Neck Cancer Clinic at the Princess Alexandra Hospital, Brisbane, Australia are invited to participate. |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To identify exposures associated with an increased risk of head and neck squamous cell carcinoma | 2 years |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| To compare subjects who have ever been exposed with those who have never been exposed. | 2 years | |
| To estimate the effect of each exposure adjusted for the confounding effects of other exposures. | 2 years |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
All patients presenting to the Head and Neck Cancer Clinic at the Princess Alexandra Hospital, Brisbane, Australia. Patients may be be new patients or old patients and may have a new diagnosis or they may have a recurrence.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Dana Middleton | Contact | 61 7 3176 3219 | dana.middleton@health.qld.gov.au |
| Name | Affiliation | Role |
|---|---|---|
| Annika Antonsson, Dr | QIMR Berghofer Medical Research Institute | Principal Investigator |
| Ben Panizza, Assoc Prof | Princess Alexandra Hospital | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Princess Alexandra Hospital | Recruiting | Brisbane | Queensland | 4102 | Australia |
Not provided
| ID | Term |
|---|---|
| D000077195 | Squamous Cell Carcinoma of Head and Neck |
| ID | Term |
|---|---|
| D002294 | Carcinoma, Squamous Cell |
| D002277 | Carcinoma |
| D009375 | Neoplasms, Glandular and Epithelial |
| D009370 | Neoplasms by Histologic Type |
Not provided
Not provided
| The University of Queensland |
| OTHER |
Not provided
Not provided
Not provided
Not provided
Participants are asked to give their consent for researchers to obtain tissue from tumour blocks. This tissue is taken as part of their normal care and treatment. If consent is given, formalin-fixed paraffin embedded (FFPE) tissue samples will be used to determine HPV status.
| To test for trends in head and neck squamous cell carcinoma | 2 years |
| Sandro Porceddu, Assoc Prof |
| Princess Alexandra Hospital |
| Principal Investigator |
| David Whiteman, Prof | QIMR Berghofer Medical Research Institute | Principal Investigator |
| D009369 | Neoplasms |
| D006258 | Head and Neck Neoplasms |
| D009371 | Neoplasms by Site |